Readnour Robin Shane 4
4 · AN2 Therapeutics, Inc. · Filed Dec 23, 2024
Insider Transaction Report
Form 4
Readnour Robin Shane
Director
Transactions
- Award
Common Stock
2024-12-19+9,077→ 9,077 total
Holdings
- 652,573(indirect: See Footnote)
Common Stock
- 582,288(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.
- [F2]MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC Venture Partners 2018, LP ("MGC 2018 LP") and MGC Venture Partners QP 2018 LP ("MGC 2018 QP"). MGC 2018 GP has shared voting and shared dispositive power over the shares held by MGC 2018 LP and MGC 2018 QP. The Reporting Person is a member of the Issuer's board of directors and is a member of MGC 2018 QP and MGC 2018 LP and a managing partner of MGC 2018 GP and has shared voting power and shared dispositive power over the shares of common stock held by MGC 2018 LP and MGC 2018 QP. The Reporting Person disclaims beneficial ownership of the securities, except to the extent of such person's pecuniary interest in such securities.
- [F3]Shares held directly by MGC 2018 LP.
- [F4]Shares held directly by MGC 2018 QP.